Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
Recent years have witnessed substantial expansion in the size of the pathology slide quality control artificial intelligence market. This market is projected to expand from $0.53 billion in 2025 to $0.64 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.3%. This historical expansion is attributable to increasing adoption of digital pathology, growing need for accurate diagnostics, rising demand for workflow automation, expansion of laboratory infrastructure, and increasing focus on quality assurance.
The pathology slide quality control artificial intelligence market size is anticipated to see significant expansion in the upcoming years. It is projected to reach $1.38 billion in 2030, with a compound annual growth rate (CAGR) of 21.0%. The projected growth is attributable to the increasing integration of artificial intelligence in pathology, rising investments in AI-based quality control, enhanced regulatory support for digital pathology, the expansion of cloud-based pathology platforms, and the growing adoption of telepathology solutions. Noteworthy trends during the forecast period include technological advancements in slide scanning, innovations in artificial intelligence (AI)-based image analysis, developments in automated tissue quality assessment, ongoing research and development in artifact detection, and improvements in stain and section quality evaluation.
Get A Free Sample Report With In-Depth Market Insights:
Pathology Slide Quality Control Artificial Intelligence (AI) Market Development Factors: What’s Supporting Demand?
The future growth of the pathology slide quality control artificial intelligence (AI) market is anticipated to be fueled by the rising volume of diagnostic tests. This increase in diagnostic volumes signifies a greater number of medical examinations and tissue analyses carried out for disease detection, primarily due to an aging demographic and broadened screening initiatives. Digital pathology innovations aid in managing these increasing diagnostic loads, as they require automated solutions to uphold precision and productivity within busy settings. Pathology slide quality control artificial intelligence (AI) contributes to establishing dependable diagnostic processes by employing machine learning algorithms to automatically detect faults, anomalies, and inconsistencies in digital slide images prior to review by a pathologist. For example, NHS England, the publicly funded healthcare system in the UK, reported an average of 2.4 million diagnostic tests conducted monthly in 2024/25, marking an 8% rise from the preceding year. Consequently, the expanding scope of diagnostic testing is propelling the expansion of the pathology slide quality control artificial intelligence (AI) market.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Segment Landscape: Which Areas Lead Development?
The pathology slide quality control artificial intelligence (AI) market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Quality Assurance Tools (Dedicated Quality Control), Pre-Analytic Quality Control, Analytic Quality Control, Post-Analytic Quality Control, Workflow Management
4) By End User: Hospitals, Diagnostic Laboratories, Research Institutes, Academic Centers, Other End Users
Subsegments:
1) By Software: Image Analysis Algorithms, Slide Quality Scoring Tools, Workflow Management Systems, Data Integration Platforms, Cloud Deployment Platforms
2) By Hardware: Digital Slide Scanners, Imaging Workstations, High Resolution Camera Systems, Computational Processing Units, Data Storage Servers
3) By Services: Installation Services, System Integration Services, Technical Support Services, Training And Education Services, Maintenance And Upgradation Services
Pathology Slide Quality Control Artificial Intelligence (AI) Market Transformation Trends: What Innovations Are Driving Change?
Leading companies operating in the pathology slide quality control artificial intelligence (AI) market are prioritizing technological advancements, such as the introduction of AI-powered automated quality control solutions integrated into digital pathology workflows. These technologies employ deep learning algorithms to automatically identify and highlight imperfections, blurry regions, and other quality issues in whole-slide images prior to pathologist examination. This approach effectively reduces manual workload, minimizes diagnostic errors, and ensures the provision of high-quality data for subsequent analysis. For example, in March 2023, Aiosyn B.V., a Netherlands-based medical software company specializing in AI-driven pathology solutions, launched AiosynQC, an AI-powered automated quality control solution. This modular software integrates with existing digital pathology systems to detect and emphasize out-of-focus areas and various artifacts in hematoxylin and eosin (H&E) stained slide images, thereby supporting a more efficient and accurate quality review process for both research and diagnostic laboratories.
Pathology Slide Quality Control Artificial Intelligence (AI) Market Leading Players And Competitive Positioning
Major companies operating in the pathology slide quality control artificial intelligence (AI) market are F. Hoffmann-La Roche Ltd., Philips Healthcare, Leica Biosystems GmbH, XIFIN Inc., Stratipath Inc., PathAI Inc., Owkin Inc., Lunit Inc., Paige.AI Inc., Proscia Inc., Visiopharm A/S, Indica Labs Inc., Inspirata Inc., PreciseDx Inc., Aiforia Technologies Oyj, Ibex Medical Analytics Ltd., Deep Bio Inc., Nucleai Ltd., AIRA Matrix Inc., HistoIndex Pte Ltd., Techcyte Inc.
View The Full Pathology Slide Quality Control Artificial Intelligence (AI) Market Report:
Pathology Slide Quality Control Artificial Intelligence (AI) Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the pathology slide quality control artificial intelligence market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pathology slide quality control artificial intelligence (AI) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
